HOWL
Werewolf Therapeutics, Inc. · Healthcare
Director Luke Evnin sold $115K of Werewolf Therapeutics, Inc.
Sold$115,234
$0.92Price
125,576Shares
−4%Stake
What HOWL did after the filing
- The stock from Wed, Nov 26 open, $0.94
- −38.8%
- S&P 500, same days
- +3.4%
Measured over 30 trading days, to the Jan 12 close.
Traded Fri, Nov 21. Filed Tue, Nov 25, 6:05 PM ET, after the close. Returns use the Nov 26 open and the Jan 12 close. Not investment advice.